TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Maximus Announces First-Ever Topical Oxytocin Cream for Mood Enhancement and Sleep Support

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Dr. Cameron Sepah
Maximus Announces First-Ever Topical Oxytocin Cream for Mood Enhancement and Sleep Support

Maximus has developed a groundbreaking topical oxytocin cream that provides sustained hormone release for up to 12-16 hours through a novel transdermal delivery technology, addressing previous challenges in maintaining therapeutic oxytocin levels.

Insights
MMS   positive

The company demonstrated scientific innovation by solving a complex hormone delivery challenge, developing a patent-pending technology with significant potential health benefits and receiving recognition as a fast-growing company